Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency disorder with no clinical or immunologic abnormalities in carrier famales. The defective gene has been localized to proximal Xp. Carrier females have nonrandom use of the X chromosome in granulocytes, lymphocytes, and monocytes. We have used the probe M27p. which detects both a variable number tandem repeat polymorphism and methylation differences between the active and inactive X chromosome, in the investigation of families referred for genetic counseling.
Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency disorder with no clinical or immunologic abnormalities in carrier famales.
The defective gene has been localized to proximal Xp. Carrier females have nonrandom use of the X chromosome in granulocytes, lymphocytes, and monocytes. We have used the probe M27p. which detects both a variable number tandem repeat polymorphism and methylation differences between the active and inactive X chromosome, in the investigation of families referred for genetic counseling.
SKOTT-ALDRICH syndrome (WAS) is an X-linked
W recessive disorder characterized by immunodeficiency, thrombocytopenia, and eczema. Infections and the hemorrhagic tendency that result from the thrombocytopenia are the main causes of early mortality. There is an increased incidence of lymphoreticular malignancies and leukemias that contributes to later morbidity and mortality. Bone marrow transplantation (BMT) is curative' but median survival is less than 10 years without BMT? Female carriers of WAS have no clinical or immunologic abnormalities.
The underlying defect in WAS is not known. The decreased size and number of platelets is a secondary phenomenon as both are corrected by ~plenectomy.~ Parkman et a14 reported the absence of a surface glycoprotein with a molecular weight of 115,000 daltons from lymphocytes of three patients. This glycoprotein, now known as sialophorin (CD43), has since been cloned and maps to chromosome 16.5 As the gene defective in WAS is on the X chromosome, the absence of sialophorin from the cell membrane must be secondary to an underlying abnormality.
In 1980 Gealy et a16 performed X-inactivation studies in an obligate carrier of WAS who was also heterozygous for the A and B isoenzymes of glucose-6-phophate dehydrogenase (G6PD). They found that while both isoenzymes were expressed in erythrocytes and neutrophils, only the A isoenzyme was expressed in platelets and T lymphocytes. This experiment was repeated in another obligate carrier female heterozygous for the A and B G6PD isoenzymes. This time only the B isoenzyme was expressed in platelets, granulocytes, monocytes, T lymphocytes, and B lymphocytes.' Few women are heterozygous for G6PD polymorphisms, but the recent development of molecular methods for studying X-inactivation patterns has allowed X chromosome use to be investigated in more carriers of WAS. Fearon et a18 investigated X-inactivation patterns in granulocytes and T and B lymphocytes from eight obligate carrier females and found nonrandom use of the X chromosome in all samples. A further study has confirmed the nonrandom use of the X chromosome in monocytes? As nonrandom use of the X chromosome has been found in all obligate carriers studied, X-inactivation patterns can be used as a carrier test for female relatives of affected males.
WAS was localized to the proximal short arm of the X chromosome by Peacocke and Siminovitch." Further linkage studies have identified markers (DXS7 and DXS14) on M27p detects the locus DXS255, which is tightly linked to WAS. As the probe that is used for investigation of X-inactivation patterns is also linked to the disease locus, it is possible to assign phase in families where this could not be done by conventional use of linked probes. The mothers of four isolated male cases had nonrandom use of the X chromosome. A new mutation was identified in one family with two affected males.
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the short arm of the X chromosome that flank the disease locus." No recombinations have been observed between TIMP, DXS255, DXS146, three markers localized between DXS7 and DXS14, and the disease
The probe M27P detects a variable-number tandem repeat polymorphism at the locus DXS255 and methylation differences between the active and inactive X chromoAs there are no Msp I restriction sites within the repeat motif, the length polymorphism can be seen in Msp I-digested DNA. The recognition site of Msp I is CCGG and its isoschizomer Hpu I1 digests DNA only if the CpG is unmethylated. At least one of the Msp I sites flanking the repeat motif is methylated on all active X chromosomes and unmethylated on most inactive X chromosomes. Thus, in DNA extracted from a sample with nonrandom X-chromosome use, only one of the polymorphic bands will be seen in the HpuII track and this band corresponds to the inactive X chromosome.
We have combined the use of M27P as a linked probe and for methylation studies. This combination has enabled us to say with greater certainty which females are carriers of WAS in families referred for genetic counseling.
MATERIALS AND METHODS

Families.
Four of the families referred for genetic counseling are shown in Fig 1. Counseling was requested for all three females in the third generation of family A. The consultand in families B, C, and D is shown by an arrow. In family C there was no previous history of WAS. An additional three mothers of sporadic males were studied. In each family at least one male had been investi- gated and fulfilled the diagnostic criteria set out by the World Health Organization Committee on Imm~nodeficiency.'~ DNA was extracted from venous blood by salting out.16 Four micrograms of DNAwas digested with Msp I from male and female family members. Eight micrograms of DNA from each female was digested with Hpa I1 because less than half of the DNA contributing to the bands in the Msp I track does so in the Hpa I1 track, where only inactive X chromosomes that are unmethylated produce DNA fragments of the same size. DNA samples from all members of a family were loaded on the same gel to allow direct comparison of bands. Msp I-and Hpa 11-digested samples from each female were loaded in adjacent wells. Electrophoresis was conducted through a 0.8% agarose gel at 2 Vicm for 72 hours. DNA was transferred to Hybond-N+ nylon membranes (Amersham International PLC, Amersham, Buckinghamshire, UK) following the manufacturer's instructions. The probe was radiolabeled by random priming. Filters were hybridized in 4X SSC, 1OX Denhardt's solution, 1% sodium dodecyl sulfate (SDS), 50 g/mL denatured salmon sperm, and lo6 disintegrations per minuteimL denatured probe at 65°C overnight. Filters were washed at a final concentration of 0.5X SSC, 0.1% SDS at 65°C and then exposed to XAR-5 film (Kodak Ltd, Hemel Hempstead, Herts, UK) at -70°C for 3 days. DNA studies.
RESULTS
A nonrandom pattern of X inactivation was found in the DNA samples from the six obligate carriers in these families.
In family A the two females inheriting the low-risk M27P allele had a random X-inactivation pattern and the female inheriting the high-risk M27P allele had nonrandom use of the X chromosome.
The consultand in family B had a 1 in 12 risk of being a carrier of WAS based on a Bayesian calculation using the pedigree information. Analysis of her DNA showed random use of the X chromosome.
The mother, 11,, of the isolated case in pedigree C, had a nonrandom X-inactivation pattern. Her mother and two sisters also had nonrandom use of the X chromosome. The allele corresponding to the inactive X in 11, was the M27P allele inherited by her affected son. The allele corresponding to the active X in 11, was the allele inherited by her normal son. Similarly, the allele corresponding to the active X in 11, was the allele inherited by her normal son. The two females in generation 111 in this family inherited the In family D, 111, inhcritcd the samc matcmal M27p allele as her sister, HI2, who had two sons with WAS. Ill2 had nonrandom Xchromosomc usc. with thc maternal X chromosomc carrying the dcfcctivc genc and allclc 4 for M27p (Fig 2) . Howcvcr, hcr mothcr and sister have a random pattcm of X inactivation, indicating that Ill2 is a carricr of WAS as thc rcsult of a new mutation. The consultand also had a random X-inactivation pattcrn. 
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In the familics invcstigatcd thcrc wcrc no discrcpancics bctwcen thc carricr status prcdictcd using M27p as a linkcd probc and the results of thc X-inactivation studics, cxccpt for family D in which a new mutation was idcntificd.
DISCUSSION
WAS has bccn mapped to proximal Xp.'" No rccombinations have been rcportcd bctwecn the discasc locus and DXS255 in 63 informativc mcioscs."." Including fcmalcs whosc carricr status has bccn dctcrmincd by study of X-inactivation pattcms, thcsc familics add 15 informativc mcioscs with no rccombinations.
Fcmalc carricrs of WAS havc bccn shown to havc a nonrandom X-inactivation pattcm in purificd ganulocytcs. monocytes. and lymphocytcs using G6PD isocnzymcs and DNA probes from thc 5' end of thc phosphoglycerate kinase gcne (PGK) and the 5' end of thc hypoxanthincguaninc-phosphoritmy1 transferase gcnc (HPRT). Thcsc probcs dctcct polymorphisms and mcthylation diffcrcnccs bctwcen thc activc and inactivc X chromosomc. Wc havc analyzed DNA cxtractcd from whole h i d and confirmcd nonrandom usc of the X chromosomc in the obligate carricrs in the pedigrccs in Fig 1. Extraction of DNA from vcnous blood rathcr than a ccll fraction is an advantage if X-inactivation studics are to be uscd as a routine carricr test in womcn at high pedigrce risk. The probc we havc uscd for studying X-inactivation pattcrns is M27p. This probc has two major advantagcs ovcr thc PGK and HPRT probes. Firstly, it dctccts a variable numbcr tandcm rcpcat polymorphism with a rcportcd hctcrozygosity ratc of ovcr 90%'' and X-inactivation studies can, thcrcforc, bc conducted in ncarly all fcmalcs rcfcrrcd. h s s than 50% of fcmalcs in thc population wc havc studicd arc hctcrozygous 2 3 4 5 6 7 8 9 1 0
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for the polymorphisms dctcctcd at the PGK and HPRT loci. Sccondly. M27p is linked lo the disease locus.
A s thc probe that we have uscd for our X-inactivation studics is closely linked to thc disease locus, it is possiblc to assign phase in familics whcrc thc pcdigrcc structurc is not amcnablc to convcntional use of linkcd probes. The band rcmaining in thc Hpa I1 track in a nonrandom sample corrcsponds to the inactive X chromosomc bccause thc Msp I sitc is mcthylatcd on thc activc X chromosome and unmcthylatcd on most inactive X chromosomcs. Thus, in individual I, in pedigree A, who has allclcs 3 and 5 in the Msp I track and allclc 3 in the Hpa I1 track, allclc 3 corrcsponds to thc inactive X, ic. the X carrying the dcfcctivc gcnc (Fig 3) . Both carrier daughters, 11, and 11, . havc inhcrited allclc 3 and havc nonrandom usc of the X chromosome. Thc two affcctcd sons of 11, have inherited allclc 3. Hcr daughtcr, Ill,, has also inhcritcd allclc 3 and has nonrandom usc of the X chromosomc with allclc 3 corrcsponding to hcr inactive X chromosome (Fig 3) . offspring, prenatal diagnosis could be offcrcd using M27p as a linkcd probc bccause the dcfcctivc gene must bc on her inactive X chromosomc and hencc will scgrcgatc with allclc 4.
X-inactivation studics were particularly useful in the mothcrs of isolatcd malc cases and in pcdigrcc D. All four mothcrs of isolated malc cases had nonrandom use of the X chromosome. Identification of carricrs by and assignment of linkagc phasc by mcthylation analysis lcad to more prccisc gcnetic counscling for fcmalc rclatives of isolated malc cascs. In pedigree D wc wcrc ablc to pinpoint whcrc thc new mutation occurrcd, allowing us to rcassurc othcr fcmalcs in the family.
X inactivation is a random cvcnt. hcnce, the percentage of cells with thc maternal X chromosome activc in a group of normal fcmalcs will form a normal distribution with a mcan of 50. In cxperimcnts using ncutral G6PD polymorphisms, FialkowIn found a mcan of 48, and the range for two standard dcviations was 25% to 71%. Similarly, while cxtrcmc skewing in thc use of the X chromosomc has bccn found using thc PGK and HPRT polymorphisms in approximately 5% of women, nonc of the women had cxclusivc use of onc X chromosomc." In thc 24 normal fcmalcs hctcrozygous for thc M27p length polymorphism that wc have invcstigated, two clear bands wcrc visiblc in the Hpa I1 track in all cases, even if thcy wcrc not of equal intcnsity. However, a normal fcmalc with X inactivation at the cxtrcmc of the normal distribution would be misclassificd as a carricr using this approach. Thc effcct of this can bc seen if we considcr a false-positive ratc of 0.01 in two women, one with a prior risk of 0.5 of being a carrier and the othcr with a prior risk of 0.01 of being a carrier. In thc first woman a nonrandom result alters her carrier probability to 0.99, but in the second woman the same result alters the carricr probability to 0.5. Bccause of the theoretical false-positive ratc using this method wc think that carricr testing by study of X-inactivation patterns should bc rcstrictcd to womcn with a high prior risk.
When a diagnosis of WAS is made, identification of carricr status in fcmalc relatives is important for genetic counseling. Thcrc is a small error ratc when using linked probcs alone for carrier dctcction due to the possibility of rccombination betwccn thc marker and disease locus at meiosis. It is not possible to idcntify ncw mutations using linked DNA markcrs. In the familics prcsentcd hcrc thcrc wcrc no discrcpancics bchuccn thc carrier status predicted using M27p as a linkcd probc and the rcsults of thc X-inactivation studics, cxccpt for family D whcrc a ncw mutation was identified by mcthylation analysis. Use of M27p for methylation analysis in WAS is more suitable than the PGKor HPRTmcthodasM27p iscloselylinkcd to thc diseasc locus. Usc of M27p allows assignment of linkage phase by mcthylation analysis in familics that do not have an adcquatc family structurc for tracking a linked probe through the family. In conclusion, wc have combined the use of M27p as a linkcd probc and for mcthylation studics to dctcrminc carrier status for WAS in familics rcfcrrcd for gcnctic counseling.
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